THERAPEUTIC HUMAN MAST CELLS, COMPOSITIONS, AND METHODS OF TREATING A TUMOR COMPRISING ADMINISTERING AUTOLOGOUS HUMAN MAST CELLS FROM ADIPOSE TISSUE

This disclosure is directed to mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; compositions comprising mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; and met...

Full description

Saved in:
Bibliographic Details
Main Authors KEPLEY, Christopher, PLOTKIN, Jesse
Format Patent
LanguageEnglish
French
Published 03.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This disclosure is directed to mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; compositions comprising mast cells obtained from adipose derived stem cells and sensitized with immunoglobulin-E targeted to a cancer antigen; and methods of treating a tumor in a subject, comprising administering to a subject a therapeutically effective amount of mast cells obtained from adipose derived stem cells, wherein the mast cells are autologous to the subject and sensitized with immunoglobulin-E targeted to a cancer antigen. La présente invention concerne des mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux et sensibilisés avec l'immunoglobuline E ciblée vers un antigène du cancer; des compositions comprenant des mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux et sensibilisées avec l'immunoglobuline E ciblée vers un antigène du cancer; et des procédés de traitement d'une tumeur chez un sujet, comprenant l'administration à un sujet d'une quantité thérapeutiquement efficace de mastocytes obtenus à partir de cellules souches dérivées du tissu adipeux, les mastocytes étant autologues pour le sujet et sensibilisés avec l'immunoglobuline E ciblée vers un antigène du cancer.
Bibliography:Application Number: WO2018US40183